NASDAQ:SIEN - Nasdaq - US82621J2042 - Common Stock - Currency: USD
0.174
-0.04 (-18.69%)
The current stock price of SIEN is 0.174 USD. In the past month the price decreased by -69.47%. In the past year, price decreased by -89.45%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ALC | ALCON INC | 29.9 | 45.13B | ||
COO | COOPER COS INC/THE | 23.91 | 17.66B | ||
ALGN | ALIGN TECHNOLOGY INC | 20.39 | 14.22B | ||
SOLV | SOLVENTUM CORP | 17.55 | 12.61B | ||
MMSI | MERIT MEDICAL SYSTEMS INC | 30.7 | 6.01B | ||
BLCO | BAUSCH + LOMB CORP | 25.4 | 5.55B | ||
LNTH | LANTHEUS HOLDINGS INC | 11.27 | 5.44B | ||
ICUI | ICU MEDICAL INC | 27.69 | 3.85B | ||
XRAY | DENTSPLY SIRONA INC | 10.14 | 3.73B | ||
HAE | HAEMONETICS CORP/MASS | 14.9 | 3.17B | ||
NEOG | NEOGEN CORP | 25.1 | 2.18B | ||
UFPT | UFP TECHNOLOGIES INC | 36.31 | 1.95B |
Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices. The company is headquartered in Irvine, California and currently employs 304 full-time employees. The company went IPO on 2014-10-29. The firm is engaged in transformative treatments and technologies focused on advancing plastic surgery. The firm provides medical aesthetics products to certified plastic surgeons and patients. The company has developed a portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The firm sells its breast implants, breast tissue expanders, and fat transfer system for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The firm's brands also include Sientra, Sientra Platinum20, Sientra Full Circle, Sientra Smooth, Sientra Teardrop, AlloX, AlloX2, Anatomical Controlled, BIOCORNEUM, Curve, Dermaspan, Luxe, Softspan, Silishield, AuraClens and Viality.
SIENTRA INC
3333 Michaelson Dr, Suite 650
Irvine CALIFORNIA 93117 US
CEO: Ronald Menezes
Employees: 304
Company Website: https://sientra.com/
Phone: 18055623500
The current stock price of SIEN is 0.174 USD. The price decreased by -18.69% in the last trading session.
The exchange symbol of SIENTRA INC is SIEN and it is listed on the Nasdaq exchange.
SIEN stock is listed on the Nasdaq exchange.
9 analysts have analysed SIEN and the average price target is 2.04 USD. This implies a price increase of 1072.41% is expected in the next year compared to the current price of 0.174. Check the SIENTRA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SIENTRA INC (SIEN) has a market capitalization of 2.08M USD. This makes SIEN a Nano Cap stock.
SIENTRA INC (SIEN) currently has 304 employees.
The Revenue of SIENTRA INC (SIEN) is expected to decline by -3.12% in the next year. Check the estimates tab for more information on the SIEN EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SIEN does not pay a dividend.
SIENTRA INC (SIEN) will report earnings on 2024-03-12, after the market close.
SIENTRA INC (SIEN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-5.57).
ChartMill assigns a fundamental rating of 1 / 10 to SIEN. Both the profitability and financial health of SIEN have multiple concerns.
Over the last trailing twelve months SIEN reported a non-GAAP Earnings per Share(EPS) of -5.57. The EPS increased by 48.9% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -42.26% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 82% to SIEN. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 61.42% and a revenue growth -3.12% for SIEN